Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Studies show people can lose 1520% of body weight with consistent use alongside a healthy lifestyle
While many people recover without specific hair-loss treatment, those with underlying pattern hair loss may benefit from earlier intervention
Its assimilated through food intake and is mainly found in products of animal origin
Tirzepatide is a dual-action GLP-1 and GIP receptor agonist that helps regulate blood sugar and appetite when injected subcutaneously, and your thigh is one of the most accessible and comfortable injection sites for consistent weekly dosing
Frequently asked questions References STEP 1 Trial: Semaglutide 2.4 mg for Weight Management (NEJM, 2021) GLP-1 Receptor Agonists: Mechanism and Clinical Use (PubMed) Semaglutide Prescribing Trends (JAMA Network Open, 2023) FDA Drug Shortage Database: Semaglutide Wegovy Prescribing Information (FDA) Endocrine Society Guidelines: Pharmacological Management of Obesity CDC: Healthy Weight Loss Safety Profile of GLP-1 RAs (PubMed, 2022) Glycogen and Water Weight (PubMed) Lean Mass Preservation During Weight Loss (PubMed) Medullary Thyroid Carcinoma Risk and GLP-1 RAs (PubMed)
Images of medication Zepbound Generic Name tirzepatide Strength 5 mg/0.5 mL injection (single-dose vial) Availability Prescription only Drug Class GLP-1 Drugs CSA Schedule Not a controlled drug Labeler / Supplier Eli Lilly and Company National Drug Code (NDC) 00002-0243 More about Zepbound (tirzepatide) Check interactions Compare alternatives Pricing & coupons Reviews (722) Drug images Latest FDA alerts (3) Side effects Dosage information During pregnancy Support group FDA approval history Drug class: GLP-1 Drugs Breastfeeding En espaol Patient resources Other brands Professional resources Other brands Related treatment guides Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
